Authors
Latest:
Improving Outcomes for Alzheimer’s Disease Patients by Supporting Their Caregivers Via TelehealthThe number of aging Americans 65 years and older is projected to nearly double over the next 40 years, reaching 80 million in 2040. As the U.S. population ages, so too does the prevalence of medically complex patients with conditions that require ongoing medical attention, limit activities of daily living or both.
Latest:
Optimizing the Management of TRDDrs Steven Levine, Patricia Ares-Romero, Samuel Nordberg, Martin Rosenzweig, and Carrie Jardine share insight on the future treatment landscape for TRD.
Latest:
Lab Testing Volume, Spend to RiseThe rise in the volume, variety and complexity of tests holds great promise for improving healthcare for patients, but also poses challenges for providers and health plans
Latest:
Top Three Reasons Why AI is Critical for Value-Based CareDriving healthcare innovation for payers, providers and patients
Latest:
Smart Money Bets on Value | Predictions for 2025Kimberly Westrich, M.A., chief strategy officer of National Pharmaceutical Council, shares her prediction for 2025.
Latest:
The Future of Wellness: Digital Health and the Human ElementThe three guiding principles of digital tool design are plan around user experience; aim high with creative, strategic thinking; and ensure that digital transformation is supported with top-down commitment.
Latest:
Meeting the Goal of Remote Patient Monitoring: Leveraging Data to Improve Clinical Workflows and Patient OutcomesA recent study found 70% of patients believe remote patient monitoring enables better care management.
Latest:
Unexpected Consequences of the Cures Act for Health Plans — and How to PrepareNew interoperability rules will soon empower individuals to access healthcare data from their smartphone.
Latest:
Quality Lab Data: Why It Matters So MuchDuplication and other errors can turn population health into a guessing game and waste time and money.
Latest:
Improving Outcomes for Alzheimer’s Disease Patients by Supporting Their Caregivers Via TelehealthThe number of aging Americans 65 years and older is projected to nearly double over the next 40 years, reaching 80 million in 2040. As the U.S. population ages, so too does the prevalence of medically complex patients with conditions that require ongoing medical attention, limit activities of daily living or both.
Latest:
18-Month Retrospective Claims Analysis Study Information on RuxolitinibPanelists discuss how the 18-month retrospective claims analysis of ruxolitinib revealed sustained efficacy in atopic dermatitis management, with significant reductions in disease flares, healthcare utilization, and concomitant medication use compared to conventional therapies, while maintaining a consistent safety profile across diverse patient populations and disease severities.
Latest:
Economic Benefits of Aligning Employee Health Insurance Contributions to Controllable Lifestyle BehaviorsBecause lifestyle behaviors are both a choice the employee makes, as well as a clear determinant of total health insurance rates, it follows that the employee’s share of contribution should adjust either upwards or downwards based on their lifestyle behaviors.
Latest:
Maximizing Outcomes for Patients, Payers and Providers with Data Accuracy and EfficiencyEmphasizing data efficiencies and quality will benefit payers and providers — and patients.
Latest:
Time to Refocus on Population Health StrategiesAs we continue to navigate the unknowns of the current pandemic, it appears we're still a long way off from living in a true post-COVID-19 era. Until then, improved health outcomes can still be realized through effective population health strategies, providing adequate financial resources that are available and encompassing all the determinants of health in communities, including social, behavioral and environmental factors.
Latest:
Using the Healthcare Utility Model to Manage Pharmacy Cost for Patients and PayersCivicaScript, a generic medication manufacturer, is modeling itself as public utility. It launched its first product, abiraterone 250 mg tablets, late last year and is gearing up to make its own low-cost insulin.
Latest:
Strengthening the Financial Foundation of FQHCs in Wake of PandemicFederally Qualified Health Centers have been the safety net for individuals in need for decades. However, even with increasing demand for their services – tripling the number of patients served to more than 28 million since 2000 – FQHCs are not immune from challenges stemming from the pandemic.
Latest:
Gilead, Asembly Biosciences Team Up. The Target is Hepatitis and HerpesAssembly Bio’s established areas of research is focused on herpesviruses (HSV), hepatitis B virus and hepatitis D virus.
Latest:
Hispanic Patients On Ventilators Are Five Times More Likely To Be Placed In Deep SedationA new study points to disparities for patients in respiratory failure, which can have dire consequences. The lead researchers talk about the implications.
Latest:
The U.S. Healthcare System is Broken: A National PerspectiveThe United States does not have a uniform health system and has no universal healthcare coverage. The health disadvantage of the U.S. relative to other high-income countries is health disparities in health services.
Latest:
Efforts are Needed from Payers for Improvements in BiosimilarsEfforts to improve education on biosimilars are a start, but payer policies must catch up to ensure real change.
Latest:
Evaluating Five-Year Efficacy Outcomes in EMPOWER-LUNG 1Panelists discuss how the five-year prognosis for advanced non-small cell lung cancer (NSCLC) has improved with PD-1 inhibitors, showing promising overall survival (OS) and progression-free survival (PFS). Cemiplimab’s outcomes align well with other PD-1/PD-L1 inhibitors, influencing clinical decisions for its use as a first-line treatment.
Latest:
Expert commentary: A focus on RSV vaccination, mpox and HIV PrEPNumerous sessions spanned the field of infectious diseases at the IDWeek 2024 meeting. This expert commentary focuses on respiratory syncytial virus (RSV) vaccination, mpox and HIV pre-exposure prophylaxis (PrEP).
Latest:
How the COVID-19 Pandemic Has Accelerated Payer-Provider CollaborationThe COVID-19 pandemic has led payers and providers to embrace electronic encrypted documents and other technology — and that has fostered greater collaboration between them.
Latest:
How the Contact Center Can Be a Driver of VBC SuccessHistorically, healthcare organizations have considered the contact center to be a cost center, a communications platform for conveying information to patients and plan members. Today, however, AI-enabled contact centers can be drivers of value, especially in a value-based care environment.
Latest:
Improving Your 2026 MA Star Ratings: Insights and RecommendationsMember experience, outcomes and medication adherence are the key areas of performance that Medicare Advantage plans should focus on to improve Star Ratings.
Latest:
Racial Disparities Are Present in Obesity-Related Cardiovascular Deaths, Study FindsOver the past 20 years, the age-adjusted mortality rate for obesity-related cardiovascular mortality increased by 415% for American Indian or Alaska Native individuals.
